Malpractice News



January 16, 2012


Novartis Issues Recall of Excedrin, NoDoz, Bufferin, and Gas-X Prevention

Novartis Consumer health Inc., has issued a voluntary recall of all lots of Excedrin and NoDoz bottles with the expiry dates of December 20, 2014 and earlier. The company is also recalling Bufferin and Gas-X Prevention products with expiry dates of December 20, 2013 or earlier.

The recall has been issued by Novartis with the knowledge of the FDA as a precautionary measure because these products may contain stray tablets, capsules, or caplets from other Novartis products. They may also contain broken or chipped tablets.

Novartis voluntarily suspended operations at the Lincoln, NE facility.

According to the FDA, the bottles may contain a mixture of products which could result

"in consumers taking the incorrect product and receiving a higher or lower strength than intended or receiving an unintended ingredient. This could potentially result in overdose, interaction with other medications a consumer may be taking, or an allergic reaction if the consumer is allergic to the unintended ingredient.

The recalled products were distributed across the United States to wholesalers and retailers.

Consumers who have purchased any of the products being recalled should stop using the product and contact the Novartis Consumer Relationship Center at 1-888-477-2403 for return packaging information. Consumers will receive a full refund. For more information visit http://www.novartis-otc.com/otc/index.html


Site design and development by Design Spike®, Inc.